TISSIUM

CompanyFranceFounded 2022

Wikidata

TISSIUM develops one asset, in human trials (ECLIPSIUM System in atraumatic tissue reconstruction). Mostly device; based in France, founded in 2022.

1
Asset
Furthest stage
Human trials
0
Trials
0
Signals

Pipeline

1
  • ECLIPSIUM System

    Biomorphic programmable polymer system for atraumatic tissue reconstruction.

    Human trials, Device, atraumatic tissue reconstruction, tissue reconstruction

Full company profiles: pipeline, trials, funding and people.

See Pro

Intelligence